The Clinical Proteomic Technologies for Cancer Initiative is a five-year, $104 million initiative to build the foundation of technologies, data, reagents and reference materials, analysis systems, and infrastructure needed to systematically advance protein biology for the diagnosis, treatment and prevention of cancer.